Siolta Therapeutics

The human microbiome has emerged as a key driver of immune dysfunction. At Siolta Therapeutics, we leverage multi-scale next-generation microbiome analyses to develop and test microbial-based therapeutics for the treatment and prevention of inflammatory diseases.

Area of focus: Therapeutics
Commencement date: March 06, 2017
Location: JLABS @ SSF